Xiangyu Medical Co. Ltd. A (688626) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.05 Million ≈ $2.64 Million USD) by net assets (CN¥2.04 Billion ≈ $298.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688626 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Xiangyu Medical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Xiangyu Medical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NeoGenomics Inc
NASDAQ:NEO
|
-0.010x |
|
Anhui Water Resources Development Co Ltd
SHG:600502
|
0.019x |
|
Rio Tinto PLC
LSE:RIO
|
0.112x |
|
Primax Electronics Ltd
TW:4915
|
0.053x |
|
Chongqing Gas Grp Corp Ltd
SHG:600917
|
0.082x |
|
MillerKnoll Inc
NASDAQ:MLKN
|
0.047x |
|
Anhui Tongfeng Electronics Co Ltd
SHG:600237
|
0.024x |
|
Guangdong South New Media Co Ltd
SHE:300770
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Xiangyu Medical Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Xiangyu Medical Co. Ltd. A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Xiangyu Medical Co. Ltd. A worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion ≈ $300.68 Million |
CN¥178.59 Million ≈ $26.13 Million |
0.087x | -19.63% |
| 2023-12-31 | CN¥2.11 Billion ≈ $308.38 Million |
CN¥227.91 Million ≈ $33.35 Million |
0.108x | +12.36% |
| 2022-12-31 | CN¥1.94 Billion ≈ $283.86 Million |
CN¥186.70 Million ≈ $27.32 Million |
0.096x | +12.88% |
| 2021-12-31 | CN¥1.95 Billion ≈ $284.70 Million |
CN¥165.88 Million ≈ $24.27 Million |
0.085x | -70.72% |
| 2020-12-31 | CN¥743.29 Million ≈ $108.77 Million |
CN¥216.40 Million ≈ $31.67 Million |
0.291x | +2.18% |
| 2019-12-31 | CN¥547.28 Million ≈ $80.08 Million |
CN¥155.94 Million ≈ $22.82 Million |
0.285x | +59.30% |
| 2018-12-31 | CN¥414.81 Million ≈ $60.70 Million |
CN¥74.20 Million ≈ $10.86 Million |
0.179x | -70.12% |
| 2017-12-31 | CN¥99.09 Million ≈ $14.50 Million |
CN¥59.31 Million ≈ $8.68 Million |
0.599x | -- |
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more